Helical tomotherapy in cervical cancer patients: Simultaneous integrated boost concept: Technique and Acute Toxicity

Strahlentherapie und Onkologie

Volumn 186, Issue 10, 2010, Pages 572-579

  Marnitz, Simone ^a   Stromberger, Carmen ^a   Kawgan Kagan, Michael ^a   Wlodarczyk, Waldemar ^a   Jahn, Ulrich ^a   Schneider, Achim ^a   Ulrich, Uwe ^b   Budach, Volker ^a   Köhler, Christhardt ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Martin Luther Hospital   (Germany)

Author keywords

Cervical cancer; Chemoradiation; Helical tomotherapy; Simultaneous boost; Toxicity

Indexed keywords

CISPLATIN;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CLIP; CURETTAGE; DIARRHEA; EVALUATION; FEMALE; GASTROINTESTINAL TOXICITY; HISTOGRAM; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LEUKOPENIA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; RADIATION DOSE; RECTUM; SIMULTANEOUS INTEGRATED BOOST; SMALL INTESTINE; TECHNIQUE; TOMOTHERAPY; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

ADULT; AGED; DOSE FRACTIONATION; FEMALE; HUMANS; INTESTINE, SMALL; LAPAROSCOPY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 78650171118     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2121-6     Document Type: Article

References (37)

1. Baglan KL, Frazier RC, Yan D, et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2002;52: 176-83. (Pubitemid 34041570)
2. Bodurka-Bevers D, Morris M, Eifel PJ, et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 2000;78:187-93. (Pubitemid 30650352)
3. Chatani M, Nose T, Masaki N, Inoue T. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Strahlenther Onkol 1998;174:504-9.
4. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-12.
5. Chen MF, Tseng CJ, Tseng CC, et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity- modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1438-44.
6. Chen MF, Tseng CJ, Tseng CC, et al. Adjuvant concurrent chemoradiotherapy with intensity modulated pelvic radiotherapy after surgery for high risk, early stage cervical cancer patents. J Cancer 2008;14:200-6.
7. Common Terminology Criteria for Adverse Events v3.0, CTCAE v3.0 (http:// ctep.cancer.gov).
8. Diagnostik und Therapie des Zervixkarzinoms. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft e.V. (DKG) und der Deutschen Gesellschaft fr Gynäkologie und Geburtshilfe (DGGG). Algorithmus 5 (http://www.awmf.de).
9. Dimopoulos JC, Schirl G, Baldinger A, et al. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009;185:282-7.
10. Engels B, de Ridder M, Tournel K, et al. Preoperative helical tomography and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 2009;74: 1476-80.
11. Georg D, Georg D, Hillbrand M, et al. Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques. Strahlenther Onkol 2008;184:586-91.
12. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy an radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6. (Pubitemid 32868726)
13. http://www.rtog.org.
14. Hänsgen G, Kuhnt T, Pigorsch S, et al. Adjuvante simultane Radiochemotherapie nach operiertem Uteruszervixkarzinom in der High-Risk-Situation. Ergebnisse einer Pilotuntersuchung. Strahlenther Onkol 2002;178:71-7. (Pubitemid 34135513)
15. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61. (Pubitemid 29177874)
16. Kirwan JM, Symonds P, Green JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003;68:217-26. (Pubitemid 38373421)
17. Lian J, Mackenzie M, Joseph K, et al. Assessment of extended field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy. Int J Radiat Oncol Biol Phys 2008;70:935-43.
18. Marnitz S, Köhler C, Roth C, et al. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 2005;99:536-44. (Pubitemid 41686533)
19. Marnitz S, Köhler C, Roth C, et al. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging. Strahlenther Onkol 2007;183:473-8. (Pubitemid 47347927)
20. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43. (Pubitemid 29177872)
21. Mundt AJ, Roeske JC, Lujan AE, et al. Initial clinical experience with intensity- modulated whole pelvis radiation therapy in patients with gynaecologic malignancies. Gynecol Oncol 2001;82:446-56.
22. Nagy V, Coza O, Ordeanu C, et al. Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial. Strahlenther Onkol 2009;185: 177-83.
23. Perez CA, Grigsby PW, Locket MA, et al. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 1999;44:855-66. (Pubitemid 29284135)
24. Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum and bladder doses in patients with cervical cancer receiving pelvic and paraaortic radiation. Int J Radiat Biol Oncol Phys 2001;51:261-6. (Pubitemid 32758886)
25. Randall ME, Ibbott GS. Intensity-modulated radiation therapy (IMRT) for gynaecologic cancers. Pitfalls, hazards, and cautions to be considered. Semin Radiat Oncol 2006;16:138-43. (Pubitemid 43928638)
26. Robertson JM, Lockman D, Yan D, et al. The doses-volume relationship of small bowel irradiation and acute grade 3 diarrhoea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:413-8.
27. Roeske JC, Lujan A, Rotmensch J, et al. Intensity modulated whole pelvis therapy in patients with gynaecologic malignancies. Int J Radiat Oncol Biol Phys 2000;48:1613-21.
28. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53. (Pubitemid 29177873)
29. Sartori E, Pasinetti B, Carrara L, et al. Pattern of failure and value of follow- up procedures in endometrial and cervical cancer patients. Gynecol Oncol 2007;107:241-7.
30. Strauss HG, Kuhnt T, Laban C, et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 2002;178:278-85.
31. Uterus-11-Studie der ARO/AGO. Prospektive, randomisierte und multizentrische Therapieoptimierungsstudie zur Untersuchung des Einflusses des operativen Stagings auf die Wahl der Therapie und die onkologischen Ergebnisse bei Patientinnen mit Zervixkarzinom der FIGO-Stadien IIB-IV (http://www.degro. org, http://www.ago.de).
32. vant Riet A, Mak AC, Moerland MA, et al. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 1997;37:731-6. (Pubitemid 27175329)
33. Vandecasteele K, De Neve W, De Gersem W, et al. Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Strahlenther Onkol 2009;185:799-807.
34. Vorwerk H, Wagner D, Christiansen H, et al. An easy irradiation technique (partial half-beam) to reduce renal dose in radiotherapy of cervical cancer including paraaortic lymph nodes. Strahlenther Onkol 2008;184:473-7.
35. Vorwerk H, Wagner D, Seitz B, et al. Overestimation of low-dose radiation in intensity-modulated radiotherapy with sliding-window technique. Strahlenther Onkol 2009;185:821-9.
36. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecology Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48. (Pubitemid 29220838)
37. Zanagnolo V, Ming L, Gadducci A, et al. Surveillance procedures for patients with cervical carcinoma: a review of the literature. Int J Gynecol Cancer 2009;19:194-201.